Literature DB >> 16740152

Mesenteric desmoid tumor of the interposed jejunal pouch after total gastrectomy.

Koichi Tamura1, Masaji Tani, Hiroyuki Kinoshita, Hiroki Yamaue.   

Abstract

BACKGROUND: Desmoid tumor is a rare entity, and most desmoid tumors are located in abdominal wall or extra-abdominal tissues. Occurrence of desmoid tumor in mesentry is extremely rare. CASE
PRESENTATION: we report a mesenteric desmoid tumor in a 73-years-old woman who had undergone total gastrectomy reconstructed with jejunal pouch interposition for gastric carcinoma. After 1 year, a tumor was originating from mesentery of the interposed jejunal pouch was identified, and the patient underwent resection of the large mass which was found to invade pancreas. Histological examination revealed desmoid tumor.
CONCLUSION: Desmoid tumor is rare, and it was difficult for the differential diagnosis of desmoid tumor or recurrent tumor.

Entities:  

Year:  2006        PMID: 16740152      PMCID: PMC1481628          DOI: 10.1186/1477-7819-4-27

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


Background

Desmoid is derived from the Greek word "desmos", meaning band-like. The tumors are defined as benign fibrous tissue tumors arising in the musculoaponeurotic structures throughout the body. There is no report of metastasis for desmoid tumor, however, desmoid tumor sometimes shows locally invasive growth [1]. Histological examination usually shows uniformed mature fibroblasts in both size and shape without karyomitosis [2]. An annual incidence of desmoid is rare, and it is reported only in 2–4 cases per 1 million populations [3]. Moreover, desmoid tumors commonly occur as an extracolonic manifestation of familial adenomatous polyposis (FAP), especially Gardner syndrome [4]. There is no report of intra-abdominal desmoid tumor after total gastrectomy, originating from the interposed jejunal pouch.

Case presentation

A 73-years-old woman had undergone total gastrectomy and D2 lymphadenectomy for gastric carcinoma, which was pathologically diagnosed as stage I (T1, N1, H0, P0, M0, CY0) by Japanese Classification of Gastric Carcinoma 2nd English edition[5]. The patient was followed-up by computed tomography (CT), and there was no tumor at 1 year after the total gastrectomy. However, another year later, she was admitted to Wakayama Medical University hospital because of asymptomatic intra-abdominal tumor. Laboratory investigations revealed a hemoglobin (Hb) of 11.7 g/dl, while the levels of serum carcinoembryonic antigen (CEA), carbohydrate antigen 125 (CA125) and carbohydrate antigen 19-9 (CA19-9) were within normal range. CT showed a 50 × 65 mm round-shaped solid mass at the right side of the reconstructed jejunal pouch, which showed weak enhancement at arterial phase by contrast medium and local invasion into pancreas body (Figure. 1). Magnetic resonance imaging (MRI) showed a low signal intensity of the mass in both T1-weighted and T2-weighted images (Figure. 2). Abdominal ultrasound revealed a hypoechoic mass without blood-flow.
Figure 1

Computed tomography (CT) shows round-shaped solid mass at the right side of the reconstructed jejunal pouch, and invaded into pancreas (arrow).

Figure 2

Magnetic resonance imaging (MRI) showed a low signal intensity of the mass in both T1-weighted (left) and T2-weighted images (right).

Computed tomography (CT) shows round-shaped solid mass at the right side of the reconstructed jejunal pouch, and invaded into pancreas (arrow). Magnetic resonance imaging (MRI) showed a low signal intensity of the mass in both T1-weighted (left) and T2-weighted images (right). At laparotomy, a 50 × 50 × 63 mm tumor was found to be located in the mesentery of the jejunal pouch which was used for reconstruction after total gastrectomy the mass was adhered to the pancreas and it was possible to separate it from pancreas. The tumor was excised and the reconstruction was performed by double tract method with esphagojejunostomy and jejunoduodenostomy. The resected specimen was shown in Figure. 3. Microscopically, the tumor was composed of spindle-shaped fibroblasts and copious collagen fibers by hematoxylin and eosin stain. Collagen fibers were positive for immunological staining of α-smooth muscle actin, confirming a desmoid tumor (Figure. 4).
Figure 3

The tumor was an elastic hard and white mass, and the size was 50 × 50 × 63 mm. It originated from the interposed mesenterium.

Figure 4

The tumor was composed of spindle-shaped fibroblasts and copious collagen fibers by hematoxylin and eosin stain (H&E). (A: × 100 B: × 400).

The tumor was an elastic hard and white mass, and the size was 50 × 50 × 63 mm. It originated from the interposed mesenterium. The tumor was composed of spindle-shaped fibroblasts and copious collagen fibers by hematoxylin and eosin stain (H&E). (A: × 100 B: × 400). She is presently doing well and has no sign of any recurrent tumor 4 years after the operation.

Discussion

Surgical trauma, which is one of the most important etiologic factors for desmoid, can induce desmoid growth [6]. However, desmoid tumor originating from the jejunal pouch, which had been interposed for reconstruction after total gastrectomy for improvement of early postoperative eating capacity, body weight and quality of life has not been reported before. The desmoid tumor originated from mesentery of reconstructed jejunal pouch, which has not been affected surgical manipulation. Although anastomotic leakage, abscess, wound infection, and fistula are the known complications of total gastrectomy, occurrence of desmoid tumor is rare [7]. In our case, there were no postoperative complications, and there was no intra-abdominal inflammatory lesion that could have led to formation of desmoid tumor. Mesenteric desmoid tumor is rare and has few symptoms associated with this tumor, thus it is difficult to diagnose these lesions early. In this case identification of a solid mass at the intra-abdominal site after total gastrectomy, possibility of a tumor recurrence was first considered and later was considered as a solitary recurrent lymph node metastasis, the diagnosis of desmoid was never considered. Surgery is the treatment of choice for desmoid tumors. The incidence of recurrence is reported to be 40%, with surgical excision alone the recurrence rate of 77% in mesenteric desmoid tumors have been reported [8]. Surgical margin has been reported as an important factor for the recurrence of desmoid, the 10-year recurrence rate for the patients with negative surgical margins is reported to be 27%, whereas it is 54% for patients with positive surgical margins [9]. Use of adjuvant radiotherapy has improved relapse rate for the patients with positive surgical margins and unresectable desmoid tumors [9]. It is suggested that if surgical resection is not possible due to some reason the patients should be treated by radiotherapy. A significant 3.5-fold increased risk for the development of desmoid tumors among females has been reported, particularly during or after pregnancy [4,10]. An increased risk for the female gender is consistent with the observation that desmoid cells may express estrogen receptors and are inhibited in their in vitro proliferation by antiestrogen compounds [11]. Tamoxifen has antiestrogen activity and it is possible to be effective in desmoid tumors [2]. The dogma prevalent in medical oncology has been that low-grade tumors with no known metastatic potential do not kill patients and may not respond to chemotherapy [12,13]. In this case, the patient was kept on observation alone as i) the surgical margin was negative and ii) advanced age of the patient. However, it was demonstrated that desmoid tumors respond to chemotherapy. Surgery was planned in this case as gastric cancer was early stage, and the recurrence are rare. If the gastric cancer had been advanced stage to begin with, we might have planned chemotherapy with the diagnosis of recurrent gastric cancer.

Conclusion

The desmoid tumor originating from the mesentry of the jejunal pouch after total gastrectomy has not been reported. It was a surprise, as desmoid tumor is rare and it was difficult to think of desmoid tumor as differential diagnosis.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

Tamura, K: Preparation of manuscript, Collection of clinical data, Operation Tani, M: Proofreading of manuscript, Operation, Collection of clinical data Kinoshita H: Collection of data, Operation Yamaue, H: Proofreading of manuscript
  12 in total

1.  Desmoid tumors and mesenteric fibromatosis in Gardner's syndrome: report of kindred 109.

Authors:  E W Naylor; E J Gardner; R C Richards
Journal:  Arch Surg       Date:  1979-10

2.  Desmoid tumors respond to chemotherapy: defying the dogma in oncology.

Authors:  Shreyaskumar R Patel; Robert S Benjamin
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

3.  Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma.

Authors:  J W Smith; M H Shiu; L Kelsey; M F Brennan
Journal:  Arch Surg       Date:  1991-12

4.  Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.

Authors:  M T Ballo; G K Zagars; A Pollack; P W Pisters; R A Pollack
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

Review 5.  Desmoids in familial adenomatous polyposis.

Authors:  S K Clark; R K Phillips
Journal:  Br J Surg       Date:  1996-11       Impact factor: 6.939

6.  Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families.

Authors:  W Friedl; R Caspari; M Sengteller; S Uhlhaas; C Lamberti; M Jungck; M Kadmon; M Wolf; J Fahnenstich; J Gebert; G Möslein; E Mangold; P Propping
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

7.  Recent trends in the management of desmoid tumors. Summary of 19 cases and review of the literature.

Authors:  D W Easter; N A Halasz
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

8.  The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population.

Authors:  J J Reitamo; P Häyry; E Nykyri; E Saxén
Journal:  Am J Clin Pathol       Date:  1982-06       Impact factor: 2.493

9.  Estrogen and antiestrogen binding sites in desmoid tumors.

Authors:  C L Lim; M J Walker; R R Mehta; T K Das Gupta
Journal:  Eur J Cancer Clin Oncol       Date:  1986-05

10.  High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.

Authors:  Anika Hansmann; Claudia Adolph; Tilmann Vogel; Andreas Unger; Gabriela Moeslein
Journal:  Cancer       Date:  2004-02-01       Impact factor: 6.860

View more
  6 in total

1.  Surgical treatment of giant mesenteric fibromatosis presenting as a gastrointestinal stromal tumor: a case report.

Authors:  Christos N Stoidis; Basileios G Spyropoulos; Evangelos P Misiakos; Christos K Fountzilas; Panorea P Paraskeva; Constantine I Fotiadis
Journal:  J Med Case Rep       Date:  2010-09-23

2.  Intra-abdominal desmoid tumor mimicking locoregional recurrence after colectomy in a patient with sporadic colon cancer: report of a case.

Authors:  Rei Mizuno; Takashi Akiyoshi; Hiroya Kuroyanagi; Yoshiya Fujimoto; Masashi Ueno; Masatoshi Oya; Hiroaki Kanda; Toshiharu Yamaguchi
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

Review 3.  Postoperative retroperitoneal desmoid tumor mimics recurrent gastrointestinal stromal tumor: a case report.

Authors:  Liang-Yu Shih; Chang-Kuo Wei; Chih-Wen Lin; Chih-En Tseng
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

4.  Intra-abdominal desmoid tumor mimicking gastric cancer recurrence: a case report.

Authors:  Akihiko Okamura; Tsunehiro Takahashi; Yoshiro Saikawa; Shuhei Mayanagi; Kazumasa Fukuda; Rieko Nakamura; Norihito Wada; Hirofumi Kawakubo; Tai Omori; Hiroya Takeuchi; Aya Sasaki; Yuko Kitagawa
Journal:  World J Surg Oncol       Date:  2014-05-10       Impact factor: 2.754

5.  Multiple mesenteric desmoid tumors after gastrectomy for gastric cancer: A case report and literature review.

Authors:  Ryusei Yamamoto; Yasuji Mokuno; Hideo Matsubara; Hirokazu Kaneko; Shinsuke Iyomasa
Journal:  Int J Surg Case Rep       Date:  2018-07-31

6.  Rapidly Growing Desmoid-Type Fibromatosis of the Mesentery of the Small Intestine after Distal Gastrectomy for Gastric Cancer.

Authors:  Ryota Koyama; Yoshiaki Maeda; Nozomi Minagawa; Toshiki Shinohara
Journal:  Case Rep Gastroenterol       Date:  2020-04-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.